A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.

J Transplant · 2012 · PMC3425854 · PMID 22934151

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

These differences in treatment regimen did not reach statistical significance.

also in 111,027 other papers

a nonsignificant trendno p-value reported

The risk of graft rejection was significantly associated with conversion in the first posttransplant year (HR 6.60) or the use of anti-CD25 antibody induction (HR 3.71), and there was a nonsignificant trend towards an increase in the risk of rejection in recipients of a deceased donor graft (HR 1.98). 4.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.